NRAS and hepatocellular carcinoma: In our study, eight IRGs (HSPA4, PSMD14, RBP2, MAPT, TRAF3, NDRG1, NRAS and IL17D) with prognostic value in HCC patients were identified by Cox regression analysis and LASSO regression modeling.